Showing 131-140 of 5789 results for "".
Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReFundamentals of Growing Your Services and Practice with Women
https://practicaldermatology.com/topics/practice-management/fundamentals-of-growing-your-services-andpractice-with-women/23052/Despite hype about men, women are the future of aesthetics. Here are seven principles to engage potential female patients, gain trust, and convert them to loyal customers.Tips to Increase Activity on your Dermatology Practice Facebook Page
https://practicaldermatology.com/topics/practice-management/tips-to-increase-activity-on-your-dermatology-prac/19602/Engaging with the Facebook users is essential to grow the business of your dermatology practice. In this Ekwa Marketing video, we share a few tips to help you expand your outreach on Facebook and sustain the necessary activity and interest on your page.The Dermatology PA Foundation: Giving Back to the Dermatology Community
https://practicaldermatology.com/topics/practice-management/the-dermatology-pa-foundation-giving-back-to-the-dermatology-community/20385/Now in its third year, the DPAF continues its focus on philanthropy, education, and research.Cash Flow: Beyond the Basics
https://practicaldermatology.com/topics/practice-management/cash-flow-beyond-the-basics/20846/How to use cash flow to your advantage and maximize business capital.Cellfina Cleared, Finacea Foam Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-cellfina-cleared-finacea-foam-approved/18866/The FDA has cleared Cellfina (Ulthera Inc./Merz Aesthetics, Inc.) to treat cellulite, with results lasting for up to 2 years. Finacea Foam (azelaic acid, Bayer Dermatology) is approved for Rosacea, and Almirall invests in Suneva Medical, maker of Bellafill. Also in this edition, a look at the data oSunscreen Water Seems All Washed Up; Fake Cosmeceuticals Raise Concerns
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-sunscreen-water-seems-all-washed-up-fake-cosmeceuticals-raise-concerns/19119/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine we take a look at drinkable sunscreen and school bans on sunscreens, get an update on Vegas Cosmetic Surgery, and meet the new face of AMBI skincare. Plus, our DermFocus investigates the problem of counterfeit cosIs Your Financial Advisor Working for You?
https://practicaldermatology.com/topics/practice-management/is-your-financial-advisor-working-for-you/21381/In first of this two-part article, the authors offer advice on important questions to ask that might give you the answer.Fringe Benefit Plans: Valuable Planning Tools You Haven't Heard Of
https://practicaldermatology.com/topics/practice-management/fringe-benefit-plans-valuable-planning-tools-you-havent-heard-of/21488/Fringe benefit plans lack many of the restrictions of qualified plans and, therefore, are relatively inexpensive to implement.New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
https://practicaldermatology.com/series/dermwire-tv/new-clinical-guidelines-for-nonmelanoma-skin-cancer-treatment-arctics-biotherapeutics-seeks-new-fda-approval-for-zoryve-foam/26745/In this week’s DermwireTV, new clinical guidelines for nonmelanoma skin cancer treatment; Arcutis Biotherapeutics seeks new FDA approval for ZORYVE foam; Practical Dermatology joins the ReachMD network; and the CEO of SofWave Medical joins us to discuss the company’s Ultrasound technology.